MEDXFMEDXFOTC
Loading
EBITDA Over TimeContracting
Percentile Rank92
3Y CAGR+3.5%
5Y CAGR+19.0%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+3.5%/yr
Annual compound
5Y CAGR
+19.0%/yr
Recent deceleration
Percentile
P92
Near historical high
vs 5Y Ago
2.4x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$16.81M-12.8%
2024$19.28M+31.6%
2023$14.65M-3.4%
2022$15.16M+164.2%
2021$-23.61M-435.6%
2020$7.04M+4324.5%
2019$159000.00+107.7%
2018$-2.06M-195.9%
2017$-697724.00+39.4%
2016$-1.15M-